PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathwayHaibo Wang, Junqi He, Wenxiu Lu et al.|British Journal of Cancer|2024Cited by 12
MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic markerHaibo Wang, Junqi He, Yibin Chen et al.|Cell Death and Disease|2025Cited by 6